AI assistant
Cartesian Therapeutics, Inc. — Director's Dealing 2016
Jun 22, 2016
33483_dirs_2016-06-21_09fa1fbe-f989-459a-984a-155c2bca280e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: SELECTA BIOSCIENCES INC (SELB)
CIK: 0001453687
Period of Report: 2016-06-21
Reporting Person: von Andrian Ulrich (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 414852 | Direct |
| Common Stock | 100642 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $7.02 | 2026-03-08 | Common Stock (25641) | Direct | |
| Stock Option (right to buy) | $3.44 | 2022-01-23 | Common Stock (73451) | Direct |
Footnotes
F1: These securities are held by The Ulrich H. von Andrian Irrevocable Trust 2008, for which the Reporting Person's spouse and sister-in-law serve as trustees. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2: This option vests in 48 substantially equal monthly installments beginning on January 1, 2016.
F3: All shares underlying this option are fully vested.